A F-circEA, a circRNA generated by EML4-ALK fusion gene, is another potential liquid biopsy biomarker as it specifically exists in the plasma of EML4-ALK-positive NSCLC patients and contributes to tumor development by promoting cell migration and invasion (Tan et al., 2018). Here, ALK is linked to non-small cell lung carcinoma.